Found: 98
Select item for more details and to access through your institution.
Interim PET‐guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced‐stage classic Hodgkin lymphoma (JCOG1305).
- Published in:
- Cancer Science, 2024, v. 115, n. 10, p. 3384, doi. 10.1111/cas.16281
- By:
- Publication type:
- Article
Classical Hodgkin lymphoma-type and monomorphic-type post-transplant lymphoproliferative disorder following liver transplantation: a case report.
- Published in:
- Surgical Case Reports, 2018, v. 4, n. 1, p. 1, doi. 10.1186/s40792-018-0480-x
- By:
- Publication type:
- Article
Advanced extramedullary hematopoiesis with a marked increase in reticulin fibers and hemorrhage on various organs: the first autopsy case report.
- Published in:
- Medical Molecular Morphology, 2022, v. 55, n. 1, p. 68, doi. 10.1007/s00795-021-00300-x
- By:
- Publication type:
- Article
Renovascular hypertension associated with JAK2 V617F positive myeloproliferative neoplasms treated with angioplasty: 2 cases and literature review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Successful Treatment of Primary Refractory Angioimmunoblastic T-cell Lymphoma With Cord Blood Transplantation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Sustained Remission of γδ T-Cell Lymphoma by Graft-Versus-Lymphoma Effect That Relapsed Early After Cord Blood Transplantation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Expression profiling of ETO2-regulated miRNAs in erythroid cells: Possible influence on miRNA abundance.
- Published in:
- FEBS Open Bio, 2013, v. 3, p. 428, doi. 10.1016/j.fob.2013.10.004
- By:
- Publication type:
- Article
Expression profiling of ETO2‐regulated miRNAs in erythroid cells: Possible influence on miRNA abundance.
- Published in:
- FEBS Open Bio, 2013, v. 3, n. 1, p. 428, doi. 10.1016/j.fob.2013.10.004
- By:
- Publication type:
- Article
Diffuse Large B-cell Lymphoma Presenting as Peritoneal Lymphomatosis: A Case Report and Literature Review.
- Published in:
- Internal Medicine, 2022, v. 61, n. 13, p. 2057, doi. 10.2169/internalmedicine.8793-21
- By:
- Publication type:
- Article
Salvage Cord Blood Transplantation for Sustained Remission of Acute Megakaryoblastic Leukemia That Relapsed Early after Myeloablative Transplantation.
- Published in:
- Internal Medicine, 2021, v. 60, n. 18, p. 3015, doi. 10.2169/internalmedicine.6796-20
- By:
- Publication type:
- Article
Case of late-onset erythropoietic protoporphyria with myelodysplastic syndrome who has homozygous IVS3-48C polymorphism in the ferrochelatase gene.
- Published in:
- Journal of Dermatology, 2017, v. 44, n. 6, p. 651, doi. 10.1111/1346-8138.13709
- By:
- Publication type:
- Article
Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes with Donor-Specific Anti-HLA Antibodies against HLA-DP.
- Published in:
- Tohoku Journal of Experimental Medicine, 2023, v. 261, n. 2, p. 123, doi. 10.1620/tjem.2023.J063
- By:
- Publication type:
- Article
Severe Bone Marrow Aplasia Following Macrophage Activation Syndrome in Systemic Lupus Erythematosus.
- Published in:
- Tohoku Journal of Experimental Medicine, 2023, v. 260, n. 4, p. 301, doi. 10.1620/tjem.2023.J037
- By:
- Publication type:
- Article
TM5614, an Inhibitor of Plasminogen Activator Inhibitor-1, Exerts an Antitumor Effect on Chronic Myeloid Leukemia.
- Published in:
- Tohoku Journal of Experimental Medicine, 2022, v. 257, n. 3, p. 211, doi. 10.1620/tjem.2022.J036
- By:
- Publication type:
- Article
Flow Cytometry-Based Photodynamic Diagnosis with 5-Aminolevulinic Acid for the Detection of Minimal Residual Disease in Multiple Myeloma.
- Published in:
- Tohoku Journal of Experimental Medicine, 2019, v. 249, n. 1, p. 19, doi. 10.1620/tjem.249.19
- By:
- Publication type:
- Article
Incidence Rate, Subtype Frequency, and Occurrence Site of Malignant Lymphoma in the Gastrointestinal Tract: Population-Based Analysis in Miyagi, Japan.
- Published in:
- Tohoku Journal of Experimental Medicine, 2018, v. 245, n. 3, p. 159, doi. 10.1620/tjem.245.159
- By:
- Publication type:
- Article
Establishment of a Screening System to Identify Novel GATA-2 Transcriptional Regulators.
- Published in:
- Tohoku Journal of Experimental Medicine, 2018, v. 244, n. 1, p. 41, doi. 10.1620/tjem.244.41
- By:
- Publication type:
- Article
Clinicopathological Features of Malignant Lymphoma in Japan: The Miyagi Study.
- Published in:
- Tohoku Journal of Experimental Medicine, 2011, v. 224, n. 2, p. 151, doi. 10.1620/tjem.224.151
- By:
- Publication type:
- Article
Diffuse large B-cell lymphoma of the skull vault.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Japanese phase Ib study of the oral PI3K-δ and -γ inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 2, p. 156, doi. 10.1007/s12185-023-03689-6
- By:
- Publication type:
- Article
Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Long-term safety profile of tirabrutinib: final results of a Japanese Phase I study in patients with relapsed or refractory B-cell malignancies.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 4, p. 553, doi. 10.1007/s12185-022-03514-6
- By:
- Publication type:
- Article
Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 2, p. 251, doi. 10.1007/s12185-022-03481-y
- By:
- Publication type:
- Article
Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 1, p. 100, doi. 10.1007/s12185-022-03455-0
- By:
- Publication type:
- Article
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 4, p. 563, doi. 10.1007/s12185-022-03379-9
- By:
- Publication type:
- Article
Unrelated cord blood transplantation for adult-onset EBV-associated T-cell and NK-cell lymphoproliferative disorders.
- Published in:
- International Journal of Hematology, 2022, v. 115, n. 6, p. 873, doi. 10.1007/s12185-022-03313-z
- By:
- Publication type:
- Article
Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma.
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 3, p. 370, doi. 10.1007/s12185-020-03024-3
- By:
- Publication type:
- Article
Dose-adjusted EPOCH with or without rituximab for aggressive lymphoma patients: real world data.
- Published in:
- International Journal of Hematology, 2020, v. 112, n. 6, p. 807, doi. 10.1007/s12185-020-02984-w
- By:
- Publication type:
- Article
Extranasal extranodal NK/T-cell lymphoma associated with systemic lupus erythematosus.
- Published in:
- International Journal of Hematology, 2020, v. 112, n. 4, p. 592, doi. 10.1007/s12185-020-02914-w
- By:
- Publication type:
- Article
Successful treatment of methotrexate-associated classical Hodgkin lymphoma with brentuximab vedotin-combined chemotherapy: a case series.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R<sup>2</sup>) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 2, p. 232, doi. 10.1007/s10147-023-02443-6
- By:
- Publication type:
- Article
Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 6, p. 816, doi. 10.1007/s10147-023-02334-w
- By:
- Publication type:
- Article
Exploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndrome.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-18921-2
- By:
- Publication type:
- Article
Phase I/II study of tirabrutinib, a second-generation Bruton's tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 122, doi. 10.1093/neuonc/noaa145
- By:
- Publication type:
- Article
Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105).
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 531, doi. 10.1111/bjh.16878
- By:
- Publication type:
- Article
Monitoring of minimal residual disease in early T-cell precursor acute lymphoblastic leukaemia by next-generation sequencing.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 2, p. 318, doi. 10.1111/bjh.13948
- By:
- Publication type:
- Article
High‐throughput liquid chromatography/electrospray ionization–tandem mass spectrometry method using in‐source collision‐induced dissociation for simultaneous quantification of imatinib, dasatinib, bosutinib, nilotinib, and ibrutinib in human plasma
- Published in:
- Biomedical Chromatography, 2021, v. 35, n. 8, p. 1, doi. 10.1002/bmc.5124
- By:
- Publication type:
- Article
A Low-Molecular-Weight Compound K7174 Represses Hepcidin: Possible Therapeutic Strategy against Anemia of Chronic Disease.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0075568
- By:
- Publication type:
- Article
Gene Expression Profiling Identifies HOXB4 as a Direct Downstream Target of GATA-2 in Human CD34+ Hematopoietic Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0040959
- By:
- Publication type:
- Article
Ibrutinib in Japanese patients with relapsed/refractory B-cell malignancies: final analysis of phase I study.
- Published in:
- 2019
- By:
- Publication type:
- clinical trial
Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Primary AL amyloidosis presenting with systemic lymphadenopathy with calcification.
- Published in:
- 2016
- By:
- Publication type:
- case study
Inhibition of human primary megakaryocyte differentiation by anagrelide: a gene expression profiling analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Identification of a novel putative mitochondrial protein FAM210B associated with erythroid differentiation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
T-cell receptor-silent peripheral T-cell lymphoma complicated with hemophagocytic lymphohystiocytosis.
- Published in:
- 2022
- By:
- Publication type:
- Letter
A novel case of γδ T cell leukemia with recurrent genetic abnormalities accompanied by agranulocytosis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Sustained remission of giant pancreatic plasmacytoma with daratumumab.
- Published in:
- 2021
- By:
- Publication type:
- Letter
A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 3, p. 743, doi. 10.1007/s00277-020-04365-z
- By:
- Publication type:
- Article
Preemptive therapy for cytomegalovirus reactivation after daratumumab-containing treatment in patients with relapsed and refractory multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- Letter